Our pharmacy has considered the threat that COVID-19 poses to public health and we are implementing strategies to minimize exposure to our patients, especially those who are most susceptible to the virus. Click here for updates on how we are serving our patients.
Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
El servicio de noticias de salud es un servicio para los usuarios de la página web de Tiffany Natural Pharmacy gracias a HealthDay. Tiffany Natural Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.